Skip to Content

755 (Temozolomide 180 mg)

Pill with imprint 755 is Orange & White, Capsule-shape and has been identified as Temozolomide 180 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc..

Temozolomide is used in the treatment of glioblastoma multiforme; anaplastic astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 180 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 755

Temozolomide

Imprint
755
Strength
180 mg
Color
Orange & White
Size
21.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Alkylating agents
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Zydus Pharmaceuticals (USA) Inc.
Manufacturer
Cadila Healthcare Limited
National Drug Code (NDC)
68382-0755
Inactive Ingredients
alcohol, ammonia, lactose anhydrous, butyl alcohol, ferric oxide red, ferric oxide yellow, ferrosoferric oxide, gelatin, isopropyl alcohol, potassium hydroxide, propylene glycol, shellac, silicon dioxide, sodium lauryl sulfate, sodium starch glycolate type B potato, stearic acid, tartaric acid, titanium dioxide, water

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "755"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.